covid 19

  1. Chandelier

    Pediatric SARS-CoV-2 long term outcomes study: chest radiographic and computed tomography findings at baseline, 2026, Zember et al.

    Pediatric SARS-CoV-2 long term outcomes study: chest radiographic and computed tomography findings at baseline Abstract Background Radiologic findings associated with SARS-CoV-2 infection have been well described since its emergence. However, long-term clinical and radiologic complications...
  2. Chandelier

    Evaluation of long-term healthcare utilization and costs associated with COVID-19 among adults and children in the US, 2026, Yehoshua et al.

    Evaluation of long-term healthcare utilization and costs associated with COVID-19 among adults and children in the US Abstract Aims This study assessed long-term healthcare resource utilization (HCRU) and direct medical costs associated with COVID-19 among adults and children in the United...
  3. Chandelier

    Lack of association between APOE genotypes and COVID‐19 in a black South African cohort, 2026, Chebii et al.

    Lack of association between APOE genotypes and COVID‐19 in a black South African cohort Abstract COVID-19 and its long-term consequences remain a major global health challenge, with host genetic factors contributing to inter-individual variation in susceptibility. Apolipoprotein E (APOE)...
  4. mariovitali

    Clinically confirmed cohort reveals antioxidant genetic polymorphisms as potential susceptibility factors for long COVID ..., 2026, Katsarou et al

    Abstract Although the COVID-19 pandemic has now been down-graded, long COVID (LC) presents an ongoing risk of long-term disease for a significant percentage of the population, even after mild or no symptoms upon infection. LC post-viral effects have been associated with oxidative stress (OS)...
  5. Casterofspells

    Widespread structural and functional brain alterations in COVID-19: a systematic review of MRI studies, 2026, Chen et al

    https://academic.oup.com/cercor/article-abstract/36/3/bhag022/8539773?redirectedFrom=fulltext Abstract The coronavirus disease 2019 (COVID-19) pandemic has not only challenged global public health but also generated interest in its neurological basis. A growing number of neuroimaging studies...
  6. Midnattsol

    Longitudinal investigation of a single variant SARS-CoV-2-outbreak in the immunologically naïve population of Ulvik, Norway, 2024, Mortensen et al

    Abstract Purpose: To perform an extensive investigation of the clinical features and long-term complications among the n = 134 adults and children with nucleic acid amplification test (NAAT) verified SARS-CoV-2-infection in the immunologically naïve population of Ulvik, Norway, during the single...
  7. John Mac

    Trial Report Vitamin D in Myalgic Encephalomyelitis/Chronic Fatigue Syndrome after COVID-19 or Vaccination: A Randomized Controlled Trial, 2026, Kodama et al

    Abstract Background: Myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) can develop as post-vaccination syndrome (PVS) or Post-Acute Sequelae of SARS-CoV-2 infection (PASC). In our prior retrospective study, most patients with PVS who developed ME/CFS had vitamin D insufficiency or...
  8. hotblack

    Combinatorial Analysis of Phenotypic and Clinical Risk Factors Associated With Hospitalized COVID-19 Patients, 2021, Das et al

    Combinatorial Analysis of Phenotypic and Clinical Risk Factors Associated With Hospitalized COVID-19 Patients Abstract Characterization of the risk factors associated with variability in the clinical outcomes of COVID-19 is important. Our previous study using genomic data identified a...
  9. Chandelier

    Characteristics of Non-intubated Older Adult With COVID-19 and Decreased Feeding and Swallowing Function and … Length of Hospital Stay, 2025, Tanaka+

    Full title: Characteristics of Non-intubated Older Adult Patients With COVID-19 and Decreased Feeding and Swallowing Function and Their Association With Length of Hospital Stay...
  10. Chandelier

    Association of 2024–2025 Covid-19 Vaccine with Covid-19 Outcomes in U.S. Veterans, 2025, Cai et al.

    https://www.nejm.org/doi/10.1056/NEJMoa2510226 Abstract BACKGROUND Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, contemporary evidence on...
  11. Chandelier

    Perceived Chronic Stress prior to SARS-CoV-2 Infection Predicts Ongoing Symptomatic COVID-19: A Prospective Cohort Study , 2025, Fazekas et al.

    https://karger.com/pps/article/doi/10.1159/000547858/934006/Perceived-Chronic-Stress-prior-to-SARS-CoV-2 Abstract Introduction: Understanding chronic stress as a potential risk factor for COVID-19 progression could inform public health measures and personalized preventive interventions...
  12. Chandelier

    Respiratory viral infections prime accelerated lung cancer growth, 2025, Qian et al.

    https://www.biorxiv.org/content/10.1101/2025.09.02.672566v1 SUMMARY The COVID-19 pandemic has highlighted long-term health concerns of viral pneumonia, yet its potential impact on cancer development and growth remains poorly understood. Here, we demonstrate that prior infection with...
  13. Chandelier

    The Common Cold Is Associated With Protection From SARS-CoV-2 Infections, 2025, Moore et al.

    https://academic.oup.com/jid/advance-article/doi/10.1093/infdis/jiaf374/8230147?login=false Abstract Background Adults and children often respond differently to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection, with adults facing a higher risk of symptomatic and severe...
  14. ahimsa

    BMJ: Why scientists are rethinking the immune effects of SARS-CoV-2

    The BMJ: Why scientists are rethinking the immune effects of SARS-CoV-2
  15. Chandelier

    Maraviroc treatment for hospitalized participants with non-severe COVID-19…: a randomized, proof-of-concept clinical trial, 2025, Gasca-Capote et al.

    Abstract Background: Therapeutic options for hospitalized people with COVID-19 remain limited, especially for people with non-severe COVID-19 at risk of progression. The anti-inflammatory role of maraviroc, a CCR5 antagonists, makes it a good candidate for therapeutic strategies for COVID-19...
  16. Wyva

    Associations of epigenetic aging and COVID- 19: A 3-year longitudinal study, 2025, Farkas et al

    Abstract Aging and COVID- 19 are known to influence DNA methylation, potentially affecting the rate of aging and the risk of disease. The physiological functions of 54 volunteers—including maximal oxygen uptake (VO₂ max), grip strength, and vertical jump—were assessed just before the COVID- 19...
  17. leokitten

    Aripiprazole as protector against COVID-19 mortality Munecas et al 2024

    https://www.nature.com/articles/s41598-024-60297-y
  18. Yann04

    Brain abnormalities in survivors of COVID-19 after 2-year recovery: a functional MRI study, Zhao et al, 2024

    Background A variety of symptoms, particularly cognitive, psychiatric and neurological symptoms, may persist for a long time among individuals recovering from COVID-19. However, the underlying mechanism of these brain abnormalities remains unclear. This study aimed to investigate the long-term...
  19. InitialConditions

    Looking for references: Initial covid infection severity and development of ME/CFS

    Is anyone aware of studies that have quantified the severity of initial COVID-19 infection and development of ME/CFS? We know that (i) ME/CFS can develop after any severity of acute infection; (ii) patients often report development of ME/CFS after mild or moderate infection; but do we have data...
  20. Nightsong

    Post-Acute Sequelae of COVID (PASC or Long COVID): An Evidenced-based Approach, 2024, Griffin

    Abstract While the acute manifestations of infectious diseases are well known, in some individuals, symptoms can either persist or appear after the acute period. Post-viral fatigue syndromes are recognized with other viral infections and are described after COVID-19. We have a growing number of...
Back
Top Bottom